Article Text

Download PDFPDF
Protein losing enteropathy-hepatic fibrosis syndrome in Saguenay-Lac St-Jean, Quebec is a congenital disorder of glycosylation type Ib
  1. S Vuillaumier-Barrot1,
  2. C Le Bizec1,
  3. P de Lonlay2,
  4. A Barnier1,
  5. G Mitchell3,
  6. V Pelletier3,
  7. C Prevost4,
  8. J M Saudubray2,
  9. G Durand1,
  10. N Seta1
  1. 1Biochimie A, Hôpital Bichat-Claude Bernard, AP-HP, 75877 Paris Cedex 18, France
  2. 2Département de Pédiatrie, Hôpital Necker, AP-HP, 75743 Paris Cedex 15, France
  3. 3Service de Génétique Médicale, Hôpital Sainte-Justine, 3175 Côte Sainte-Catherine, Montréal, Canada
  4. 4Service de Génétique, Centre Hopitalier de la Sagamie, Canada
  1. Correspondence to:
 Dr N Seta, Laboratoire de Biochimie A, Hopital Bichat-Claude Bernard46 Rue Henri Huchard, 75877 Paris Cedex 18, France;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Congenital disorders of glycosylation (CDG) are newly described inborn errors of metabolism involving glycan moiety synthesis. CDG Ib is caused by a deficiency of cellular phosphomannose isomerase (EC–4 resulting from the presence of mutations in the corresponding gene, MPI,5,6 on chromosome 15 (mutation database: CDG Ib differs clinically from the other CDGs. It has no neurological symptoms, presenting mainly with hepatic and gastrointestinal symptoms2,3,7,8 and is thought to be underdiagnosed. Fewer than 20 CDG Ib patients have been reported. Importantly, CDG Ib is treatable by oral mannose supplementation, in contrast with other CDGs.3,9

The syndrome of intractable diarrhoea of infancy was first defined in 1968 by Avery et al.10 In 1986, a syndrome of intractable diarrhoea associated with severe protein losing enteropathy, hypoglycaemia, and congenital hepatic fibrosis, was described in four infants from the Saguenay-Lac St-Jean (SLSJ) region of north eastern Quebec, Canada. All died before 21 months of age.11

In retrospect, their symptoms resembled those of CDG Ib. In this article we describe the testing of parents of these children and report on a new French family with CDG Ib. The French-Canadian parents were all heterozygous for the same deleterious MPI mutation as found in the new French patient, proving that the SLSJ patients in fact suffered from CDG 1b.



The clinical presentation of the SLSJ infants was previously described by Pelletier et al.11

The new French patient with CDG Ib, whose family originates from Nantes (Brittany, France) and whose parents have no known consanguinity, presented with diarrhoea related to protein losing enteropathy with oedema, hypoalbuminaemia, hyponatraemia, and recurrent hypoglycaemia. No liver cytolysis was noted. Hypocholesterolaemia was found and clotting tests showed thrombocytosis. Coagulation factor XI was decreased, resulting in an …

View Full Text